Philippe Goupille

Nerve ingrowth into diseased intervertebral disc in chronic back pain

TE Peacock, Philippe Goupille, JA Hoyland et al. · The Lancet · 1997 · 978 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

Florence Tubach, Dominique Salmon, Philippe Ravaud et al. · Arthritis & Rheumatism · 2009 · 631 citations · Full text

Medicine, Immunology, Infectious Diseases +13

Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study

Xavier Chevalier, Philippe Goupille, A. D. Beaulieu et al. · Arthritis Care & Research · 2009 · 525 citations · Full text

Medicine, Orthopaedic Surgery, Pharmacotherapy +16

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Peter Nash, Bruce Kirkham, Masato Okada et al. · The Lancet · 2017 · 405 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14